Trans-Pacific Partnership: Trade deal could force Australian Government to spend millions to subsidise medicines, expert warns
19-Mar-2015 Australia Broadcasting Corporation Australia’s primary negotiator on medicines for the US-Australia FTA, Dr Ruth Lopert, warns that the TPP could force the Australian Government to spend hundreds of millions of dollars to subsidise medicines.
29-Aug-2011 The Scavenger
An anti-Free Trade Agreement protest that took place outside an International Congress on AIDS in the Asia Pacific (ICAAP) in Busan, South Korea, on 27 August was violently attacked by police.
12-Aug-2011 Patent Docs
Last week, a group of seven House Democrats, led by Rep. Henry Waxman (D-CA), sought to have the 12-year data exclusivity period provided by the biosimilar approval pathway of the US’ Patient Protection and Affordable Care Act excluded from the Trans-Pacific Partnership agreement
India’s Department of Pharmaceuticals will take up issues with the Commerce Ministry regarding the proposed Trans Pacific Partnership Agreement which is likely to have adverse impact on the Indian pharma products, and other such Free Trade Agreements in the pipeline.
27-Jul-2011 NY Times
The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China — middle-income countries, all — as if they or their governments could pay hundreds or even thousands of dollars a year each for AIDS drugs.
CETA IPR chapter will likely have a slight positive effect on specific industries in the EU, such as agri-food companies using geographical indications. It would also benefit the Canadian publishing industry and the innovative pharmaceutical industry. At the same time, an IPR chapter in CETA could lead to notable negative effects in Canada, for example via higher prices on educational and pharmaceutical products.
Le président de l’Association Internationale du Sida (IAS), l’Ougandais Elly Katabira, a invité dimanche, tous les pays du monde de faciliter l’accès aux médicaments contre la maladie, y compris les génériques, par des nouvelles lois ou règlements.
The Society of Chemical Manufacturers and Affiliates (SOCMA) issued its support this week of the passage of pending free-trade agreements (FTA) with South Korea, Panama and Colombia by two Congressional committees. SOCMA is the US-based trade association representing custom and batch manufacturers, including contract manufacturers of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients.
15-Jul-2011 Public Service Europe
Conflict between European and Indian pharma industries might be played out again in FTAs with other nations
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over.
Pharmaceuticals might not have been the most discussed sector before the Korea-European Union Free Trade Agreement came into effect from July 1.
Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.
3-Jul-2011 ACT UP-Paris
This morning, in a small town in the region of Gent, Belgium, activists from Act Up-Paris woke up the European Commissioner for Trade in front of his house. They unfurled a banner which said ‘De Gucht, AIDS accomplice’.
29-Jun-2011 Prensa Libre
El relator especial de las Naciones Unidas sobre el Derecho a la Salud, Anand Grover, detectó el aumento en el precio de algunos medicamentos, debido al TLC con EE. UU., y sugiere la compra de fármacos genéricos.
5 WikiLeaks revelations exposing the rapidly growing corporatism dominating American diplomacy abroad
One of WikiLeaks’ greatest achievements has been to expose the exorbitant amount of influence that multinational corporations have over Washington’s diplomacy.
The Asia Pacific Network of Positive People (APN+) is expressing outrage at ongoing free trade agreement negotiations by the United States with Vietnam and Malaysia that threaten access to medicines for HIV, TB, hepatitis-C as well as other diseases in these countries.
Statement of May 2011 against the increasingly rapid spread of Free Trade Agreements that put the profits of multinational pharmaceutical companies ahead of people’s right to health around the world.
India formally announced at the UN High Level Meeting on HIV and AIDS that it will not accept data exclusivity, a provision harmful to access to affordable medicines, as part of a free trade agreement currently being negotiated with the European Union.
The TPP chapter may be best seen as a significant step toward the pharmaceutical industry’s ultimate goal, which is a binding international agreement on drug pricing that would restrain the ability of governments to use collective purchasing power to demand prices below “market” levels.
Pharmac is being targeted by US drug companies as trade negotiations continue with the United States.
As the global community meets in New York for the United Nations General Assembly High Level Meeting on HIV and AIDS from 8 to 10 June 2011, networks of People living with HIV, health groups and treatment activists from around the world are calling for an immediate moratorium on all Free Trade Agreements (FTAs) and TRIPS-plus measures.